DEUTSCHE BANK AG\ - AKARI THERAPEUTICS PLC ownership

AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 10 filers reported holding AKARI THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of AKARI THERAPEUTICS PLC
ValueSharesWeighting
Q4 2019$1,000
-99.6%
1,027
-99.2%
0.00%
Q2 2019$266,000
+291.2%
132,000
+594.7%
0.00%
Q1 2019$68,000
+423.1%
19,000
+493.8%
0.00%
Q4 2017$13,000
-59.4%
3,200
-39.6%
0.00%
Q3 2017$32,000
+433.3%
5,300
+278.6%
0.00%
Q2 2017$6,000
-97.7%
1,400
-94.0%
0.00%
Q1 2017$258,000
+57.3%
23,3870.0%0.00%
Q4 2016$164,000
-17.6%
23,3870.0%0.00%
Q3 2016$199,000
-36.8%
23,3870.0%0.00%
Q2 2016$315,000
+34.0%
23,3870.0%0.00%
Q1 2016$235,000
-17.8%
23,387
+18.2%
0.00%
Q4 2015$286,00019,7870.00%
Other shareholders
AKARI THERAPEUTICS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 4,103,098$2,585,0003.26%
Omnia Family Wealth, LLC 782,372$493,0000.40%
ARMISTICE CAPITAL, LLC 4,290,000$2,703,0000.05%
Bryn Mawr Capital Management, LLC 100,000$63,0000.02%
NEA Management Company, LLC 452,167$285,0000.01%
Hikari Power Ltd 130,821$82,0000.01%
Truvestments Capital LLC 1,621$1,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 30,264$19,0000.00%
MILLENNIUM MANAGEMENT LLC 37,544$24,0000.00%
Renaissance Technologies 40,050$25,0000.00%
View complete list of AKARI THERAPEUTICS PLC shareholders